The true battle over Stephen Hawking's final theory isn't physics; it's about legacy curation and the multi-million dollar industry of posthumous genius.
Local support for stem cell research hides a massive ethical and economic battleground. Who truly profits from this 'good cause'?
The annual Rocky Mountain IP Institute convenes, but the real battle for **technology** dominance isn't in the lecture halls—it's in the shadows of **patent litigation**.
Forget the glossy press releases. The true impact of science and tech initiatives in Kano reveals a deeper geopolitical struggle over digital sovereignty.
Five women from the Global South won a top energy award. But who is truly funding this 'progress' and what does it mean for real **sustainable energy** innovation?
The journey from academic 'eureka' to commercial patent is broken. We dissect the hidden costs of **technology transfer** and **intellectual property** management.
The Croom Medical ACOT expansion signals massive medical device manufacturing growth, but what does this mean for Irish tech talent migration?
The race for **small modular reactor (SMR) technology** isn't just about clean power; it's a geopolitical battle where established giants clash with disruptive startups like Oklo for **nuclear innovation** dominance.
The promise of combined newborn gene and biomarker screening hides a darker truth about genetic privacy and the future of personalized medicine.
Cornell's Mehta Group pushes 'precision nutrition' tech. This isn't about health; it's about data control in the future of food security.
Forget the breakthroughs. The real story in February's science snapshots isn't discovery, it's geopolitical control over future technology.
Forget the doom-and-gloom narratives. Apple, Microsoft, and OpenAI's massive Irish investments signal a dangerous, hyper-concentrated shift in global **technology employment**.